Guardian Pharmacy Services, Inc.’s (NYSE:GRDN) Lock-Up Period Set To End on March 25th

Guardian Pharmacy Services’ (NYSE:GRDN) lock-up period is set to end on Tuesday, March 25th. Guardian Pharmacy Services had issued 8,000,000 shares in its IPO on September 26th. The total size of the offering was $112,000,000 based on an initial share price of $14.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the expiration of the lock-up period.

Guardian Pharmacy Services Stock Performance

Guardian Pharmacy Services stock opened at $21.36 on Friday. The firm’s fifty day moving average is $20.55. Guardian Pharmacy Services has a 12 month low of $14.16 and a 12 month high of $25.74.

Hedge Funds Weigh In On Guardian Pharmacy Services

Institutional investors and hedge funds have recently modified their holdings of the stock. R Squared Ltd purchased a new position in shares of Guardian Pharmacy Services during the 4th quarter valued at $30,000. Investment Research & Advisory Group Inc. acquired a new stake in shares of Guardian Pharmacy Services in the 4th quarter valued at $34,000. BNP Paribas Financial Markets acquired a new stake in shares of Guardian Pharmacy Services in the 4th quarter valued at $37,000. Compass Financial Services Inc acquired a new stake in shares of Guardian Pharmacy Services in the 4th quarter valued at $58,000. Finally, JPMorgan Chase & Co. acquired a new stake in shares of Guardian Pharmacy Services in the 4th quarter valued at $77,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.